Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mychitol Plus is a dietary supplement developed and marketed by AGP in Pakistan, formulated specifically to support women's reproductive health, manage symptoms of polycystic ovary syndrome (PCOS), and improve fertility. It is a fixed-dose combination containing myo-inositol, D-chiro-inositol, L-methylfolate, and manganese. The combination of myo-inositol and D-chiro-inositol in a physiological 40:1 ratio helps restore insulin sensitivity, regulate the menstrual cycle, and promote healthy ovulation. L-methylfolate provides a highly bioactive form of folate to support cell division and prevent neural tube defects during early pregnancy, while manganese acts as an essential cofactor for antioxidant defense. Mychitol Plus is supplied as oral sachets to be dissolved in water.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mychitol Plus.